 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/358861
Chinese Diabetes Diagnostics Markets
|
Description: |
This analysis is available through our Pharmaceutical and Clinical Diagnostics Growth Partnership Services program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data as well as many interactive features including Analyst Inquiry Time and Client Councils.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research service:
- Laboratory diabetes diagnostics
- POCT diabetes diagnostics
Technologies
The following technologies are covered in this research:
- Automation: Laboratory automation can be defined broadly as any device, software, or process that improves the efficiency of the laboratory.
- Integration: The act of integrating various automated tasks into a continuous process.
- Total Lab Automation (TLA): The definition of TLA is the combination of several instruments, consolidated instruments, workcells, integrated workcells, or integrated modular workcells that are coupled to a specimen management and transportation system as well as a process control software component to automate a large percent of laboratory work.
- Point-of-Care Testing (POCT): Pathology investigation by or on behalf of the treating medical practitioner on-site. It is a diagnostic testing conducted close to the site where clinical care is delivered.
Market Overview
Large Untapped Potential Drives Future Growth of Chinese Diabetes Diagnostics Markets
Increasing incidences of diabetes in China leading to higher volumes of diagnostic tests is the primary driver for the growth of the Chinese diabetes diagnostics markets. These markets grew by 6.8 per cent from 2004 to 2005 and are expected to see a compound annual growth rate (CAGR) of 9.8 percent from 2005-2012. Considering that only about 15.0 per cent of the Chinese diabetic population of 30.0 million is diagnosed with this disease and also that an alarmingly high 85.0 percent remains undiagnosed, these markets present massive untapped opportunities, remarks the analyst of this research service.
Laboratory diagnostics have long prevailed as the ‘golden standard’ for diabetes diagnosis, contributing to nearly 85.0 per cent of the total diabetes diagnostics market revenues in 2005. The majority of hospital laboratories in China - about 60.0 per cent - continue to favor these methods due to their proven ability and effectiveness. However, emerging point-of-care testing (POCT) diagnostics are generating substantial interest, largely due to their shorter turnaround time and could well challenge the position of laboratory testing as the preferred method of diabetes diagnostics.
POCT Diagnostics Set for Strong Growth
Although POCT diagnostics currently account for a very small share of the total diabetes diagnostics tests performed, they are expected to be used in much higher proportions by 2012 and could eat into the shares of laboratory testing. This emerging segment contributed to 15.0 per cent of the total diabetes diagnostics market revenues in 2005. This relatively low figure can perhaps be attributed to the fact that POCT has predominantly been used in the inpatient departments of hospitals, since the bulk of POCT meters are placed at hospitals’ critical wards. In fact, the POCT segment derived 95.0 per cent of its total revenues through instruments placed in such locations.
However, these meters are expected to increasingly find their way into physicians’ clinics and laboratories as POCT instruments meet with greater acceptance in terms of their quality and accuracy, says the analyst. The diagnosis of diabetes in patients admitted for a different disease, unrelated to diabetes, has also bolstered the growth of revenues in this segment.
|
|
Contents: |
1. Executive Summary
- 1. Market Dynamics
- - 1. Market Overview
- - 2. Industry Challenges
- 2. Market Engineering Measurements
- - 1. Market Stage
- - 2. Market Revenues
- - 3. Market Growth Rate
- - 4. Market Potential
- - 5. Customer Priorities
- - 6. Customer Loyalty
- 3. Market Revenue Forecast
- - 1. Market Revenue Forecasts
- 4. Competitive Structure
- - 1. Competitive Structure
2. Research and Market Overview
- 1. Research Overview
- - 1. Research Scope and Methodology
- - 2. Market Segmentation
- - 3. Glossary of Terms
- 2. Market Overview
- - 1. Introduction
- - 2. Industry Challenges
- - 3. Market Drivers
- - - a. Rapidly Increasing Aging Population Increasing the Demand for Diabetes Testing
- - - b. Changing Lifestyle Bound to Increase the Obese, Overwieght Population and Thereby the Incidence of Diabetes
- - - c. Growing Affluent Population and Awareness Improves the Regular Health Check-ups and Thereby More Tests
- - - d. Government Encouraging Higher Participation of Private Health Insurance Participants
- - - e. The Quick and User-friendly POCT Meters Encouraging Patients for More Regular Health Check-ups
- - 4. Market Restraints
- - - a. Low Diagnostic Rates of Diabetes
- - - b. Limited Accessibility of Rural Population to Modern Healthcare Facilities
- - - c. Expensive Distribution Network
- - - d. Low Medical Insurance Coverage
- - - e. Local Low-cost Reagent Suppliers
3. Market Engineering Measurements
- 1. Market Analysis
- - 1. Comparison of the Laboratory and POCT Diabetes Diagnostics Segments
- - 2. Market Stage
- - 3. Market Revenues
- - 4. Market Growth Rate
- - 5. Market Potential
- - 6. Pricing
- - 7. Degree of Competition
- 2. End User Analysis
- - 1. Customer Sites
- - 2. Test Volumes
- - 3. Customer Priorities
- - 4. Customer Loyalty
- 3. Technological Trends
- - 1. Laboratory Diabetes Diagnostics Segment
- - 2. POCT Diabetes Diagnostics Segment
- 4. Distribution Structure and Trends
- - 1. Market Distribution Structure
- - 2. Trends in Distribution
- 5. Reimbursement Environment
- - 1. Reimbursement Environment
4. Competitive Structure and Revenue Forecasts
- 1. Competitive Structure
- - 1. Competitive Framework
- - 2. Tiers of Competition
- - 3. Chinese Diabetes Diagnostics Market Share Analysis
- - 4. Laboratory Diabetes Diagnostics Market Share Analysis
- - 5. POCT Diabetes Diagnostics Segment Market Share Analysis
- 2. Revenue Forecasts
- - 1. Revenue Forecasts for the Diabetes Diagnostics Market
- - 2. Revenue Forecasts for Laboratory Diabetes Diagnostics Segment-- 3. Revenue Forecasts for the POCT Diabetes Diagnostics Segment
5. Conclusion
- 1. Strategic Recommendations
- - 1. Strategic Recommendations
- 2. Recommendation for Industry Challenges
- - 1. Recommendations
6. Appendix
- 1. Decision Support Database Tables
- - 1. Diabetes Prevalence Percentage
- - 2. Obese Population
- - 3. Number of Hospitals
- - 4. Male Population above 65 Years of Age
- - 5. Female Population Above 65 years of Age
- 2. Database of Key Industry Participants
- - 1. Database of Key Industry Participants
List Of Figures
- Diabetes Diagnostics Market: Impact of Top Industry Challenges (China), 2006-2012
- Diabetes Diagnostics Market: Market Drivers Ranked in Order of Impact (China), 2006-2012
- Diabetes Diagnostics Market: Market Restraints Ranked in Order of Impact (China), 2006-2012
- Diabetes Diagnostics Market: Market Revenues by Segments (China), 2005
- Diabetes Diagnostics Market: Market Potential Forecasts (China), 2002-2012
- Diabetes Diagnostics Market: Shifting of Customer Priorities (China), 2005 & 2012
- Diabetes Diagnostics Market: Company Market Share by Revenues (China), 2005
- Laboratory Diabetes Diagnostics Market: Company Market Share by Revenues (China), 2005
- POCT Diabetes Diagnostics Market: Company Market Share by Revenues (China), 2005
- Diabetes Diagnostics Market: Revenue Forecasts (China), 2002-2012
- Laboratory Diabetes Diagnostics Market: Revenue Forecasts (China), 2002-2012
- POCT Diabetes Diagnostics Market: Revenue Forecasts (China), 2002-2012
|
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/358861
Order by Fax - using the order form below
Order By Post - print the order form below and send to
|
|
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2
Printed 29/11/2009 04:11:55 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
|
Product Name: |
Chinese Diabetes Diagnostics Markets
|
|
Web Address: |
http://www.researchandmarkets.com/reports/358861
|
|
Office Code: |
|
OC8HJNPOUMUXU
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Electronic (PDF)
- Site License
|
|
€5,709.00
|
|
Electronic (PDF)
- Enterprisewide
|
|
€6,716.00
|
|
Electronic and Hard Copy (PDF)
- Enterprisewide
|
|
€7,052.00 + EUR€ 50.00 Shipping/Handling *
|
|
Electronic and Hard Copy (PDF)
- Site License
|
|
€6,044.00 + EUR€ 50.00 Shipping/Handling *
|
* Shipping/Handling is only charged once per order.
Contact information
Please enter all the information below in BLOCK CAPITALS.
|
|
|
First Name: |
Last Name: |
|
Email Address: |
|
|
Job Title: |
|
|
Organisation: |
|
|
Address: |
|
|
City: |
|
|
Postal/Zip Code: |
|
|
Country: |
|
|
Phone Number: |
|
|
Fax Number: |
|
|
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
|
Page 2 of 2
Printed 29/11/2009 04:11:55
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
|
American Express
|
|
|
Diners Club
|
|
|
Master Card
|
|
|
Visa
|
|
|
|
|
|
|
Cardholder's Name: |
|
|
|
|
Cardholder's Signature: |
|
|
|
|
Expiry Date: |
/ |
|
|
|
Card Number: |
|
|
|
|
CVV Security Code: |
|
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
|
|
|
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
|
|
|
|
Please transfer funds to:
|
|
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
|
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
|
|
|
|
|
